Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind, placebo-controlled, multicenter phase II studyChong Wang, Junqi Niu, Bei Zhong et al.|EClinicalMedicine|2025Cited by 7
LBP-014 HBsAg loss and seroconversion after 16-week or 24-week AHB-137 treatment in HBeAg-negative chronic hepatitis B participants on NA therapy: results from an ongoing multicenter, randomized phase IIb studyYanhang Gao, Junqi Niu, Xieer Liang et al.|Journal of Hepatology|2025Cited by 2
OS-075 Dual plasma molecular adsorption system therapy in patients with acute-on-chronic liver failure: a non-randomized clustercontrolled study (PADSTONE)Beiling Li, Jinjun Chen, Rongqi Wang et al.|Journal of Hepatology|2025Cited by 0